Diagnosis of Burkitt lymphoma using an algorithmic approach - applicable in both resource-poor and resource-rich countries

British Journal of Haematology

Volumn 154, Issue 6, 2011, Pages 770-776

  Naresh, Kikkeri N ^a   Ibrahim, Hazem A H ^a,k   Lazzi, Stefano ^b   Rince, Patricia ^c   Onorati, Monica ^b   Ambrosio, Maria R ^b   Bilhou Nabera, Chrystèle ^c   Amen, Furrat ^a   Reid, Alistair ^a   Mawanda, Michael ^d   Calbi, Valeria ^d   Ogwang, Martin ^d   Rogena, Emily ^e   Byakika, Bessie ^f   Sayed, Shahin ^g   Moshi, Emma ^h   Mwakigonja, Amos ^h,i   Raphael, Martine ^c   Magrath, Ian ^j   Leoncini, Lorenzo ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d St Mary's Hospital   (Uganda)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Nairobi Hospital   (Kenya)

^g AGA KHAN UNIVERSITY   (Kenya)

^h MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

ⁱ MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^j INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

^k MANSOURA UNIVERSITY   (Egypt)

more..

Author keywords

Diagnostic haematology; Immunophenotyping; Lymphoma

Indexed keywords

CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HERMES ANTIGEN; KI 67 ANTIGEN; MICRORNA; PROTEIN BCL 2;

AFRICA SOUTH OF THE SAHARA; ARTICLE; B CELL LYMPHOMA; BCL6 GENE; BURKITT LYMPHOMA; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; EUROPE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

DIAGNOSTIC HAEMATOLOGY; IMMUNOPHENOTYPING; LYMPHOMA;

ADULT; ALGORITHMS; BURKITT LYMPHOMA; CHILD; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; HEALTH RESOURCES; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE;

EID: 80052266202     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08771.x     Document Type: Article

References (20)

1. Barrans, S., Crouch, S., Smith, A., Turner, K., Owen, R., Patmore, R., Roman, E. & Jack, A. (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 3360-3365.
2. Chuang, S.S., Ye, H., Du, M.Q., Lu, C.L., Dogan, A., Hsieh, P.P., Huang, W.T. & Jung, Y.C. (2007) Histopathology and immunohistochemistry in distinguishing burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. American Journal of Clinical Pathology, 128, 558-564.
3. Dave, S.S., Fu, K., Wright, G.W., Lam, L.T., Kluin, P., Boerma, E.J., Greiner, T.C., Weisenburger, D.D., Rosenwald, A., Ott, G., Muller-Hermelink, H.K., Gascoyne, R.D., Delabie, J., Rimsza, L.M., Braziel, R.M., Grogan, T.M., Campo, E., Jaffe, E.S., Dave, B.J., Sanger, W., Bast, M., Vose, J.M., Armitage, J.O., Connors, J.M., Smeland, E.B., Kvaloy, S., Holte, H., Fisher, R.I., Miller, T.P., Montserrat, E., Wilson, W.H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W.C., Staudt, L.M. & Lymphoma/Leukemia Molecular Profiling Project (2006) Molecular diagnosis of burkitt's lymphoma. The New England Journal of Medicine, 354, 2431-2442.
4. Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T.F., Bernd, H.W., Cogliatti, S.B., Dierlamm, J., Feller, A.C., Hansmann, M.L., Haralambieva, E., Harder, L., Hasenclever, D., Kuhn, M., Lenze, D., Lichter, P., Martin-Subero, J.I., Moller, P., Muller-Hermelink, H.K., Ott, G., Parwaresch, R.M., Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Sturzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H.H., Spang, R., Loeffler, M., Trumper, L., Stein, H., Siebert, R. & Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe (2006) A biologic definition of burkitt's lymphoma from transcriptional and genomic profiling. The New England Journal of Medicine, 354, 2419-2430.
5. Johnson, N.A., Savage, K.J., Ludkovski, O., Ben-Neriah, S., Woods, R., Steidl, C., Dyer, M.J., Siebert, R., Kuruvilla, J., Klasa, R., Connors, J.M., Gascoyne, R.D. & Horsman, D.E. (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood, 114, 2273-2279.
6. de Jong, D., Xie, W., Rosenwald, A., Chhanabhai, M., Gaulard, P., Klapper, W., Lee, A., Sander, B., Thorns, C., Campo, E., Molina, T., Hagenbeek, A., Horning, S., Lister, A., Raemaekers, J., Salles, G., Gascoyne, R.D. & Weller, E. (2009) Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the lunenburg lymphoma biomarker consortium). Journal of Clinical Pathology, 62, 128-138.
7. Keller, C.E., Nandula, S., Fisher, J., Subramaniyam, S., Vakiani, E., Savage, D.G., Murty, V.V., Alobeid, B. & Bhagat, G. (2008) The spectrum of B-cell non-hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. American Journal of Clinical Pathology, 130, 193-201.
8. Kluin, P.M., Harris, N.L., Stein, H., Leoncini, L., Raphael, M., Campo, E. & Jaffe, E.S. (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 265. IARC, Lyon, France.
9. Ladanyi, M., Offit, K., Jhanwar, S.C., Filippa, D.A. & Chaganti, R.S. (1991) MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood, 77, 1057-1063.
10. Lenze, D., Leoncini, L., Hummel, M., Volinia, S., Liu, C.G., Amato, T., De Falco, G., Githanga, J., Horn, H., Nyagol, J., Ott, G., Palatini, J., Pfreundschuh, M., Rogena, E., Rosenwald, A., Siebert, R., Croce, C.M. & Stein, H. (2011) The different epidemiologic subtypes of burkitt lymphoma share a largely homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia, in press.
11. Leoncini, L., Raphael, M., Stein, H., Harris, N.L., Jaffe, E.S. & Kluin, P.M. (2008) Burkitt lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 262. IARC, Lyon, France.
12. Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., Tosi, P., van Krieken, H. & Leoncini, L. (2008) MYC translocation-negative classical burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. The Journal of Pathology, 216, 440-450.
13. Mead, G.M., Barrans, S.L., Qian, W., Walewski, J., Radford, J.A., Wolf, M., Clawson, S.M., Stenning, S.P., Yule, C.L., Jack, A.S. & UK National Cancer Research Institute Lymphoma Clinical Studies Group & Australasian Leukaemia and Lymphoma Group (2008) A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood, 112, 2248-2260.
14. Niitsu, N., Okamoto, M., Miura, I. & Hirano, M. (2009) Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 23, 777-783.
15. Piccaluga, P.P., De Falco, G., Kustagi, M., Gazzola, A., Agostinelli, C., Tripodo, C., Leucci, E., Onnis, A., Astolfi, A., Sapienza, M.R., Bellan, C., Lazzi, S., Tumwine, L., Mawanda, M., Ogwang, M., Calbi, V., Formica, S., Califano, A., Pileri, S.A. & Leoncini, L. (2011) Gene expression analysis uncovers similarity and differences among burkitt lymphoma subtypes. Blood, 117, 3596-3608.
16. Raphael, M., Gentilhomme, O., Tulliez, M., Byron, P.A. & Diebold, J. (1991) Histopathologic features of high-grade non-hodgkin's lymphomas in acquired immunodeficiency syndrome. the french study group of pathology for human immunodeficiency virus-associated tumors. Archives of Pathology & Laboratory Medicine, 115, 15-20.
17. van Rijk, A., Mason, D., Jones, M., Cabecadas, J., Crespo, M., Cigudosa, J.C., Garcia, J.F., Leoncini, L., Cocco, M., Hansmann, M.L., Mottok, A., Copie Bergman, C., Baia, M., Anagnostou, D., Pouliou, E., Hamilton Dutoit, S., Hjollund Christiansen, M., Svenstrup Poulsen, T., Hauge Matthiesen, S., van Dongen, J. & van Krieken, J.H. (2008) Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach. Journal of Hematopathology, 1, 119-126.
18. Rodig, S.J., Vergilio, J.A., Shahsafaei, A. & Dorfman, D.M. (2008) Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. The American Journal of Surgical Pathology, 32, 113-122.
19. Snuderl, M., Kolman, O.K., Chen, Y.B., Hsu, J.J., Ackerman, A.M., Dal Cin, P., Ferry, J.A., Harris, N.L., Hasserjian, R.P., Zukerberg, L.R., Abramson, J.S., Hochberg, E.P., Lee, H., Lee, A.I., Toomey, C.E. & Sohani, A.R. (2010) B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from burkitt lymphoma and diffuse large B-cell lymphoma. The American Journal of Surgical Pathology, 34, 327-340.
20. Tomita, N., Tokunaka, M., Nakamura, N., Takeuchi, K., Koike, J., Motomura, S., Miyamoto, K., Kikuchi, A., Hyo, R., Yakushijin, Y., Masaki, Y., Fujii, S., Hayashi, T., Ishigatsubo, Y. & Miura, I. (2009) Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica, 94, 935-943.